000			01359 a2200409 4500
005			20250516043005.0
264		0	_c20110907
008			201109s 0 0 eng d
022			_a1460-2105
024	7		_a10.1093/jnci/djr220 _2doi
040			_aNLM _beng _cNLM
100	1		_aLagiou, Pagona
245	0	0	_aInflammatory biomarkers and risk of lung cancer. _h[electronic resource]
260			_bJournal of the National Cancer Institute _cJul 2011
300			_a1073-5 p. _bdigital
500			_aPublication Type: Comment; Editorial
650	0	4	_aBiomarkers, Tumor _xblood
650	0	4	_aC-Reactive Protein _xmetabolism
650	0	4	_aCase-Control Studies
650	0	4	_aHumans
650	0	4	_aInflammation _xblood
650	0	4	_aInterleukin-6 _xblood
650	0	4	_aInterleukin-8 _xblood
650	0	4	_aLung Neoplasms _xblood
650	0	4	_aOdds Ratio
650	0	4	_aPredictive Value of Tests
650	0	4	_aResearch Design
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aSmoking _xadverse effects
650	0	4	_aSmoking Cessation
650	0	4	_aTime Factors
650	0	4	_aUnited States _xepidemiology
700	1		_aTrichopoulos, Dimitrios
773	0		_tJournal of the National Cancer Institute _gvol. 103 _gno. 14 _gp. 1073-5
856	4	0	_uhttps://doi.org/10.1093/jnci/djr220 _zAvailable from publisher's website
999			_c20939798 _d20939798